Nyxoah SA
NYXH- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001857190
No open-market purchases or sales by Nyxoah SA insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $37.5M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Nyxoah SA as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- 0 vs. Q4 2022
- Shares held
- 2.37M
- −277.4K (−10.5%) vs. Q4 2022
- Total value
- $17.6M
- +$4.33M (+32.5%) vs. Q4 2022
- New holders
- 5
- 4 more added
- Sold out
- 5
- 2 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NYXH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $37.5M |
| Q1 2026 | 34 | $10.4M |
| Q4 2025 | 33 | $16.8M |
| Q3 2025 | 32 | $13.5M |
| Q2 2025 | 31 | $29.2M |
| Q1 2025 | 26 | $41.8M |
| Q4 2024 | 22 | $54.4M |
| Q3 2024 | 20 | $39.1M |
| Q2 2024 | 21 | $29.4M |
| Q1 2024 | 19 | $29.3M |
| Q4 2023 | 16 | $9.76M |
| Q3 2023 | 17 | $18.2M |
| Q2 2023 | 16 | $21.1M |
| Q1 2023 | 18 | $17.6M |
| Q4 2022 | 18 | $13.3M |
| Q3 2022 | 20 | $18.1M |
| Q2 2022 | 22 | $28.1M |
| Q1 2022 | 18 | $59.1M |
| Q4 2021 | 16 | $60.9M |
| Q3 2021 | 18 | $75.1M |
| Q2 2021 | 1 | $5.75M |
| Q1 2021 | 1 | $7.18M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Nyxoah SA; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 17 | $127 | 0.00% | 00.0% | Unchanged |
| Optiver Holding B.V. | 25 | $187 | 0.00% | −653−96.3% | Reduced |
| Bank of America Corp | 280 | $2.09K | 0.00% | +280 | New |
| FMR LLC | 509 | $3.77K | 0.00% | +509 | New |
| Citigroup Inc | 631 | $4.72K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 12,991 | $96.0K | 0.00% | +2,215+20.6% | Added |
| ExodusPoint Capital Management, LP | 12,971 | $97.0K | 0.00% | +12,971 | New |
| DekaBank Deutsche Girozentrale | 33,200 | $242.0K | 0.00% | 00.0% | Unchanged |
| Opaleye Management Inc. | 57,585 | $430.2K | 0.13% | +57,585 | New |
| Rossmore Private Capital | 117,940 | $881.5K | 0.14% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 137,891 | $965.0K | 0.00% | +137,891 | New |
| Pura Vida Investments, LLC | 131,129 | $978.3K | 0.10% | −18,002−12.1% | Reduced |
| Goldman Sachs Group Inc | 157,781 | $1.18M | 0.00% | +49,609+45.9% | Added |
| Sio Capital Management, LLC | 188,875 | $1.41M | 0.70% | +172,765+1,072.4% | Added |
| Putnam Investments LLC | 192,942 | $1.43M | 0.00% | 00.0% | Unchanged |
| AXA S.A. | 217,000 | $1.62M | 0.01% | +3,000+1.4% | Added |
| Deerfield Management Company, L.P. (Series C) | 455,262 | $3.40M | 0.08% | 00.0% | Unchanged |
| BlackRock Inc. | 653,319 | $4.88M | 0.00% | 00.0% | Unchanged |
| Invesco Ltd. | 0 | $0 | 0.00% | −370,980−100.0% | Sold out |
| RTW Investments, LP | 0 | $0 | 0.00% | −269,993−100.0% | Sold out |
| Evolutionary Tree Capital Management, LLC | 0 | $0 | 0.00% | −54,345−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −208−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −1−100.0% | Sold out |